YS BIOPHARMA TO MERGE WITH NASDAQ-LISTED SUMMIT HEALTHCARE ACQUISITION CORP.
Transaction values YS Biopharma at pre-money equity value of $834 million Certain investors ("Forward Purchase Investors") are expected to invest $30 million...
Stay updated with breaking news from Background Paper. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Transaction values YS Biopharma at pre-money equity value of $834 million Certain investors ("Forward Purchase Investors") are expected to invest $30 million...
Egged on by professed Christians, the Department of Defense and Department of the Air Force appear to be turning a blind eye to the facts surrounding a vaccine recently approved by the FDA for emergency use.
An Air Force veteran and attorney is calling into question the Pentagon and Air Force’s promotion of Novavax ...
Exposure drafts on proposed changes to Australia's uniform defamation laws, which focus on online defamation and victims of crime, have been released…
A study in the journal Buildings looks at how design discourses and practices can be used to both alleviate the negative effects of (un-)natural disasters and lead to good post-disaster regeneration.